Outcomes for lymph node-positive cutaneous melanoma over two decades.

Steve R Martinez1, Warren H Tseng, Shawn E Young

  • 1Department of Surgery, Division of Surgical Oncology Sacramento, University of California at Davis, 4501 X Street, Suite 3010, Sacramento, CA 95817, USA. steve.martinez@ucdmc.ucdavis.edu

Summary

Melanoma survival rates for node-positive patients have not improved over two decades. While melanoma-specific survival (MSS) has seen a slight increase, overall survival (OS) remains unchanged, suggesting stage migration may be a factor.